Danny Rischin

Fear of Cancer Recurrence in Survivors of Human Papillomavirus-Associated Oropharyngeal Carcinoma.

Georgina Casswell, Karla Gough, Allison Drosdowsky, Mathias Bressel, Andrew Coleman, Sudi Shrestha, Ieta D'Costa, Tsien Fua, Albert Tiong, Chen Liu, Danny Rischin, Lachlan McDowell

Journal article  |  2021  |  Int J Radiat Oncol Biol Phys

PURPOSE: To estimate the prevalence of and characteristics associated with fear of cancer recurrence (FCR) among human papillomavi..

Patient-reported quality of life and symptom burden measures in human papillomavirus associated oropharyngeal cancer-A review of the literature and PRO methodology

Lachlan McDowell, Karla Gough, Madeleine King, June Corry, Danny Rischin

Journal article  |  2021  |  ORAL ONCOLOGY

The emergence of human papillomavirus-associated oropharyngeal cancer (HPVOPC) has resulted in an explosion of clinical research o..

Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009

Kevin J Harrington, Ezra EW Cohen, Lillian Siu, Danny Rischin, Lisa Licitra, Jan Vermorken, Le Quynh, Makoto Tahara, Jean-Pascal Machiels, Natalyn Hawk, Joy Ge, Behzad Bidadi, Ramona F Swaby, Barbara Burtness

Conference Proceedings  |  2021  |  ORAL ONCOLOGY

First-Line Pembrolizumab With or Without Lenvatinib in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 3 LEAP-010 Study

Kevin Harrington, Lillian L Siu, Barbara Burtness, Ezra Cohen, Lisa Licitra, Danny Rischin, Ying Zhu, Chinyere E Okpara, Cecilia Pinheiro, Ramona F Swaby, Jean-Pascal Machiels, Makoto Tahara

Conference Proceedings  |  2021  |  ORAL ONCOLOGY

Sexual Health and Interpersonal Relationships After Chemoradiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A Cross-sectional Study

Georgina Casswell, Karla Gough, Allison Drosdowsky, Mathias Bressel, Andrew Coleman, Sudi Shrestha, Ieta D'Costa, Tsien Fua, Albert Tiong, Chen Liu, Danny Rischin, Lachlan McDowell

Journal article  |  2021  |  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

PURPOSE: To examine sexual health, including sexual satisfaction, and perceived changes in relationships and sexual relationships ..

Care plus study: a multi-site implementation of early palliative care in routine practice to improve health outcomes and reduce hospital admissions for people with advanced cancer: a study protocol

Jennifer Philip, Roslyn Le Gautier, Anna Collins, Anna K Nowak, Brian Le, Gregory B Crawford, Nicole Rankin, Meinir Krishnasamy, Geoff Mitchell, Sue-Anne McLachlan, Maarten IJzerman, Robyn Hudson, Danny Rischin, Tanara Vieira Sousa, Vijaya Sundararajan

Journal article  |  2021  |  BMC HEALTH SERVICES RESEARCH

BACKGROUND: Current international consensus is that 'early' referral to palliative care services improves cancer patient and famil..

Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Hani Babiker, Irene Brana, Daruka Mahadevan, Taofeek Owonikoko, Emiliano Calvo, Danny Rischin, Victor Moreno, Kyriakos P Papadopoulos, Marka Crittenden, Silvia Formenti, Jordi Giralt, Pilar Garrido, Ainara Soria, Asuncion Hervas-Moron, Kosalai Kal Mohan, Matthew Fury, Israel Lowy, Melissa Mathias, Minjie Feng, Jingjin Li, et al.

Journal article  |  2021  |  ONCOLOGIST

LESSONS LEARNED: Cemiplimab in combination with radiation therapy, cyclophosphamide, and granulocyte macrophage colony-stimulating..

Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).

Linda R Mileshkin, Kathleen N Moore, Elizabeth Barnes, Val Gebski, Kailash Narayan, Nathan Bradshaw, Yeh Chen Lee, Katrina Diamante, Anthony W Fyles, William Small, David K Gaffney, Pearly Khaw, Susan Brooks, J Spencer Thompson, Warner King Huh, Matthew Carlson, Cara Amanda Mathews, Danny Rischin, Martin R Stockler, Bradley J Monk

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

LBA3 Background: Cervical cancer is a common cause of cancer-related death among women worldwide. Standard treatment for locally ..

Identification of good and poor prognosis HPV associated oropharyngeal cancer based on CD103 immune cell expression in patients treated with cetuximab and radiotherapy on TROG 12.01 and De-ESCALaTE randomized trials.

Danny Rischin, Hisham Mohamed Mehanna, Richard J Young, Mathias Bressel, Janet Dunn, June Corry, Tessa Fulton-Lieuw, Gulnaz Iqbal, Lizbeth M Kenny, Sandro Porceddu, Christopher Wratten, Max Robinson, Benjamin J Solomon

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

109 Background: Trials in human papilloma virus associated oropharyngeal squamous cell carcinoma (HPVOPSCC), substituting cetuxim..

Final analysis of a phase 1b, randomized, multicenter study of talimogene laherparepvec (T-VEC) plus pembrolizumab (pembro) combination for the treatment (Tx) of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC): MASTERKEY-232.

Kevin Joseph Harrington, Anthony Kong, Nicolas Mach, Jason Alan Chesney, Beatriz Castelo, Danny Rischin, Ezra EW Cohen, Hoi-Shen Radcliffe, Burak Gumuscu, Wendy Snyder, Lillian L Siu

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

6036 Background: T-VEC, a genetically modified herpes simplex virus-1, is the first FDA- and EMA-approved oncolytic viral immunot..